anti p53 antibody Search Results


92
Miltenyi Biotec rea1132
Immunophenotyping panel for multiplexed tissue imaging of cancer.
Rea1132, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p53+antibody/p53+Antibody%2C+anti-human%2C+REAfinity/pmc10985204-105-2-10
Average 92 stars, based on 1 article reviews
rea1132 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

91
Boster Bio p53 antibody
Network pharmacology analysis identifies <t>p53</t> as a core ferroptosis-related target of FF in UC. ( A ) Venn diagram illustrating the intersection of FF compound targets with ferroptosis- and UC-related targets. ( B ) Protein–protein interaction (PPI) network of the common targets. Node size and color intensity represent the degree of connectivity, with TP53 (p53) identified as the core target. ( C ) Compound-target-pathway network diagram. The inner pink nodes represent the 38 intersecting targets linking FF, UC, and ferroptosis. ( D ) Gene Ontology (GO) enrichment analysis of the common targets, categorized into Biological Process (BP, red), Cellular Component (CC, green), and Molecular Function (MF, blue). ( E ) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis.
P53 Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p53+antibody/Anti-Phospho-p53+(Ser392)+TP53+Antibody/pmc12938764-97-1-6
Average 91 stars, based on 1 article reviews
p53 antibody - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

93
St Johns Laboratory rabbit anti di methyl tp53 lys370
Network pharmacology analysis identifies <t>p53</t> as a core ferroptosis-related target of FF in UC. ( A ) Venn diagram illustrating the intersection of FF compound targets with ferroptosis- and UC-related targets. ( B ) Protein–protein interaction (PPI) network of the common targets. Node size and color intensity represent the degree of connectivity, with TP53 (p53) identified as the core target. ( C ) Compound-target-pathway network diagram. The inner pink nodes represent the 38 intersecting targets linking FF, UC, and ferroptosis. ( D ) Gene Ontology (GO) enrichment analysis of the common targets, categorized into Biological Process (BP, red), Cellular Component (CC, green), and Molecular Function (MF, blue). ( E ) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis.
Rabbit Anti Di Methyl Tp53 Lys370, supplied by St Johns Laboratory, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p53+antibody/Anti-Di-Methyl-p53+(K370)+antibody/pmc11083188-196-23-26
Average 93 stars, based on 1 article reviews
rabbit anti di methyl tp53 lys370 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
Biosynth Carbosynth p53
FIGURE 1 – Percentage of tumors with Bcl-2 over-expression according to the number of accumulated oncogene alterations (c-Myc, EGFR and c-erbB-2) and <t>p53</t> status (mutated vs. non-mutated tumors).
P53, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p53+antibody/Anti-p53+antibody/aZsG1OXuMVIKPmnhlOoqK0NGAHTiYjVIhzUUNxbBpVtXaC1Bk3Y7T14hSIIzJtix3usNXycmdpWCVKE-48-3-30
Average 90 stars, based on 1 article reviews
p53 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

92
St Johns Laboratory anti p53
FIGURE 1 – Percentage of tumors with Bcl-2 over-expression according to the number of accumulated oncogene alterations (c-Myc, EGFR and c-erbB-2) and <t>p53</t> status (mutated vs. non-mutated tumors).
Anti P53, supplied by St Johns Laboratory, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p53+antibody/Anti-P53+antibody/10__5187_slash_jast__2500300-118-21-22
Average 92 stars, based on 1 article reviews
anti p53 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

93
Boster Bio n cadherin primary antibody
FIGURE 1 – Percentage of tumors with Bcl-2 over-expression according to the number of accumulated oncogene alterations (c-Myc, EGFR and c-erbB-2) and <t>p53</t> status (mutated vs. non-mutated tumors).
N Cadherin Primary Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p53+antibody/Anti-N+Cadherin%2FCDH2+Antibody+Picoband/10__32604_slash_biocell__2025__070402-103-30-34
Average 93 stars, based on 1 article reviews
n cadherin primary antibody - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

91
Boster Bio pb9008
FIGURE 1 – Percentage of tumors with Bcl-2 over-expression according to the number of accumulated oncogene alterations (c-Myc, EGFR and c-erbB-2) and <t>p53</t> status (mutated vs. non-mutated tumors).
Pb9008, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p53+antibody/Anti-P53%2FTP53+Antibody+Picoband/pm41707646-436-37-35
Average 91 stars, based on 1 article reviews
pb9008 - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

90
Boster Bio antibodies targeting p53
FIGURE 1 – Percentage of tumors with Bcl-2 over-expression according to the number of accumulated oncogene alterations (c-Myc, EGFR and c-erbB-2) and <t>p53</t> status (mutated vs. non-mutated tumors).
Antibodies Targeting P53, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p53+antibody/Anti-P53+Tp53+Monoclonal+Antibody/10__31594_slash_commagene__1662649-75-22-26
Average 90 stars, based on 1 article reviews
antibodies targeting p53 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Atlas Antibodies α p53
FIGURE 1 – Percentage of tumors with Bcl-2 over-expression according to the number of accumulated oncogene alterations (c-Myc, EGFR and c-erbB-2) and <t>p53</t> status (mutated vs. non-mutated tumors).
α P53, supplied by Atlas Antibodies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p53+antibody/Anti-p53/pm26426684-125-42-48
Average 90 stars, based on 1 article reviews
α p53 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Aviva Systems p53 antibody
( a ) Representative immunoblots corresponding to total and phosphorylated protein content measured in the nuclear and cytosolic fractions, before (Pre), immediately (+0 h) and 3 h (+3 h) after the CE and SIE trials. p-p38 MAPK Thr180/Tyr182 : bottom band at ~38 kDa; PHF20: top band at ~105 kDa. No band was detected in the nuclear fractions for p-ACC Ser79 . ( b ) Confirmation of the <t>p53</t> antibody specificity; samples were run beside an untagged full length p53 recombinant human protein and blotted against both total-p53 (positive control) and p-p53 Ser15 (negative control) antibodies. S: sample; RP: p53 recombinant protein. ( c ) Histone H3 and LDHA were used as indicators of cytosolic and nuclear enrichment, respectively. N: nuclear fractions; C: cytosolic fractions. ( d ) Whole-lane Coomassie blue staining for both nuclear and cytosolic fractions, and ( e ) histone H3 (nuclear) and GAPDH (cytosolic), were used to verify equal loading between lanes. The immunoblot and whole-lane Coomassie images in this figure were cropped to improve the conciseness and clarity of the presentation.
P53 Antibody, supplied by Aviva Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p53+antibody/Anti-P53+Antibody+(Phospho-Ser37)+(OAAI00469)/pmc05345041-51-4-20
Average 90 stars, based on 1 article reviews
p53 antibody - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

94
Boster Bio mouse monoclonal anti pidd1
( a ) Representative immunoblots corresponding to total and phosphorylated protein content measured in the nuclear and cytosolic fractions, before (Pre), immediately (+0 h) and 3 h (+3 h) after the CE and SIE trials. p-p38 MAPK Thr180/Tyr182 : bottom band at ~38 kDa; PHF20: top band at ~105 kDa. No band was detected in the nuclear fractions for p-ACC Ser79 . ( b ) Confirmation of the <t>p53</t> antibody specificity; samples were run beside an untagged full length p53 recombinant human protein and blotted against both total-p53 (positive control) and p-p53 Ser15 (negative control) antibodies. S: sample; RP: p53 recombinant protein. ( c ) Histone H3 and LDHA were used as indicators of cytosolic and nuclear enrichment, respectively. N: nuclear fractions; C: cytosolic fractions. ( d ) Whole-lane Coomassie blue staining for both nuclear and cytosolic fractions, and ( e ) histone H3 (nuclear) and GAPDH (cytosolic), were used to verify equal loading between lanes. The immunoblot and whole-lane Coomassie images in this figure were cropped to improve the conciseness and clarity of the presentation.
Mouse Monoclonal Anti Pidd1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p53+antibody/Anti-PIDD+PIDD1+Antibody/bio_rxiv__64898__2026__02__25__707964-331-12-15
Average 94 stars, based on 1 article reviews
mouse monoclonal anti pidd1 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

92
Rockland Immunochemicals rabbit anti p53
( a ) Representative immunoblots corresponding to total and phosphorylated protein content measured in the nuclear and cytosolic fractions, before (Pre), immediately (+0 h) and 3 h (+3 h) after the CE and SIE trials. p-p38 MAPK Thr180/Tyr182 : bottom band at ~38 kDa; PHF20: top band at ~105 kDa. No band was detected in the nuclear fractions for p-ACC Ser79 . ( b ) Confirmation of the <t>p53</t> antibody specificity; samples were run beside an untagged full length p53 recombinant human protein and blotted against both total-p53 (positive control) and p-p53 Ser15 (negative control) antibodies. S: sample; RP: p53 recombinant protein. ( c ) Histone H3 and LDHA were used as indicators of cytosolic and nuclear enrichment, respectively. N: nuclear fractions; C: cytosolic fractions. ( d ) Whole-lane Coomassie blue staining for both nuclear and cytosolic fractions, and ( e ) histone H3 (nuclear) and GAPDH (cytosolic), were used to verify equal loading between lanes. The immunoblot and whole-lane Coomassie images in this figure were cropped to improve the conciseness and clarity of the presentation.
Rabbit Anti P53, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+p53+antibody/p53+K305+Ac+Antibody/pmc03590842-327-53-47
Average 92 stars, based on 1 article reviews
rabbit anti p53 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

Image Search Results


Immunophenotyping panel for multiplexed tissue imaging of cancer.

Journal: Frontiers in Immunology

Article Title: Unveiling spatial complexity in solid tumor immune microenvironments through multiplexed imaging

doi: 10.3389/fimmu.2024.1383932

Figure Lengend Snippet: Immunophenotyping panel for multiplexed tissue imaging of cancer.

Article Snippet: p53 , REA1132 , 50 , 130-119-502 , PE , Miltenyi Biotec.

Techniques: Imaging

Network pharmacology analysis identifies p53 as a core ferroptosis-related target of FF in UC. ( A ) Venn diagram illustrating the intersection of FF compound targets with ferroptosis- and UC-related targets. ( B ) Protein–protein interaction (PPI) network of the common targets. Node size and color intensity represent the degree of connectivity, with TP53 (p53) identified as the core target. ( C ) Compound-target-pathway network diagram. The inner pink nodes represent the 38 intersecting targets linking FF, UC, and ferroptosis. ( D ) Gene Ontology (GO) enrichment analysis of the common targets, categorized into Biological Process (BP, red), Cellular Component (CC, green), and Molecular Function (MF, blue). ( E ) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis.

Journal: Antioxidants

Article Title: Saposhnikovia divaricata Inhibits Inflammation, Oxidative Stress, and Ferroptosis to Alleviate DSS-Induced Ulcerative Colitis

doi: 10.3390/antiox15020258

Figure Lengend Snippet: Network pharmacology analysis identifies p53 as a core ferroptosis-related target of FF in UC. ( A ) Venn diagram illustrating the intersection of FF compound targets with ferroptosis- and UC-related targets. ( B ) Protein–protein interaction (PPI) network of the common targets. Node size and color intensity represent the degree of connectivity, with TP53 (p53) identified as the core target. ( C ) Compound-target-pathway network diagram. The inner pink nodes represent the 38 intersecting targets linking FF, UC, and ferroptosis. ( D ) Gene Ontology (GO) enrichment analysis of the common targets, categorized into Biological Process (BP, red), Cellular Component (CC, green), and Molecular Function (MF, blue). ( E ) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis.

Article Snippet: The p53 antibody was obtained from Boster Biological Technology Co., Ltd. (Pleasanton, CA, USA, Item #BM0101).

Techniques:

FF modulates the expression of ferroptosis-related proteins in colon tissue via the p53 pathway. ( A ) Representative immunohistochemical (IHC) images of p53, SLC7A11, and GPX4 expression in colon sections (scale bar = 50 μm). ( B – D ) Quantitative analysis of the relative protein expression levels of p53 (B), SLC7A11 (C), and GPX4 (D). Data are presented as the mean ± SD ( n = 3 independent experiments). ### p < 0.001 versus the control (CON) group; * p < 0.05, ** p < 0.01, *** p < 0.001 versus the DSS model group.

Journal: Antioxidants

Article Title: Saposhnikovia divaricata Inhibits Inflammation, Oxidative Stress, and Ferroptosis to Alleviate DSS-Induced Ulcerative Colitis

doi: 10.3390/antiox15020258

Figure Lengend Snippet: FF modulates the expression of ferroptosis-related proteins in colon tissue via the p53 pathway. ( A ) Representative immunohistochemical (IHC) images of p53, SLC7A11, and GPX4 expression in colon sections (scale bar = 50 μm). ( B – D ) Quantitative analysis of the relative protein expression levels of p53 (B), SLC7A11 (C), and GPX4 (D). Data are presented as the mean ± SD ( n = 3 independent experiments). ### p < 0.001 versus the control (CON) group; * p < 0.05, ** p < 0.01, *** p < 0.001 versus the DSS model group.

Article Snippet: The p53 antibody was obtained from Boster Biological Technology Co., Ltd. (Pleasanton, CA, USA, Item #BM0101).

Techniques: Expressing, Immunohistochemical staining, Control

FIGURE 1 – Percentage of tumors with Bcl-2 over-expression according to the number of accumulated oncogene alterations (c-Myc, EGFR and c-erbB-2) and p53 status (mutated vs. non-mutated tumors).

Journal: International Journal of Cancer

Article Title: Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: A pathway to metastatic progression in human breast cancer

doi: 10.1002/(sici)1097-0215(20000320)89:2<142::aid-ijc7>3.0.co;2-b

Figure Lengend Snippet: FIGURE 1 – Percentage of tumors with Bcl-2 over-expression according to the number of accumulated oncogene alterations (c-Myc, EGFR and c-erbB-2) and p53 status (mutated vs. non-mutated tumors).

Article Snippet: Bcl-2, c-Myc, c-erbB-2, p53, EGFR and hormone receptor (PR, ER) expression Expression of these genes was assessed by immuno-histochemistry (IHC) using appropriate antibodies: the monoclonal antibody (MAb) anti-Bcl-2 124 (ICI, Cambridge Research Biochemicals, Northwich, UK) at 1:200 dilution; MAb to p53, clone BP-53-12-1 (Biogenex, San Ramon, CA); MAb Ab-6, clone DO-1 (Oncogene Science, Uniondale, NY); MAb Ab-1, clone 9E10 (Oncogene Science), which reacts with human c-Myc at 1:100 dilution; MAb anti-C-erbB-2, clone CB11 (Biogenex) at 1:80 dilution; MAb anti-EGFR, clone E30 (Merck, Darmstadt, Germany) at 1:15 dilution.

Techniques: Over Expression

FIGURE 2 – Percentage of tumors with p53 over-expression according to the number of accumulated oncogene alterations (c-Myc, EGFR and c-erbB-2) and histological grade (I/II or III).

Journal: International Journal of Cancer

Article Title: Bcl-2 with loss of apoptosis allows accumulation of genetic alterations: A pathway to metastatic progression in human breast cancer

doi: 10.1002/(sici)1097-0215(20000320)89:2<142::aid-ijc7>3.0.co;2-b

Figure Lengend Snippet: FIGURE 2 – Percentage of tumors with p53 over-expression according to the number of accumulated oncogene alterations (c-Myc, EGFR and c-erbB-2) and histological grade (I/II or III).

Article Snippet: Bcl-2, c-Myc, c-erbB-2, p53, EGFR and hormone receptor (PR, ER) expression Expression of these genes was assessed by immuno-histochemistry (IHC) using appropriate antibodies: the monoclonal antibody (MAb) anti-Bcl-2 124 (ICI, Cambridge Research Biochemicals, Northwich, UK) at 1:200 dilution; MAb to p53, clone BP-53-12-1 (Biogenex, San Ramon, CA); MAb Ab-6, clone DO-1 (Oncogene Science, Uniondale, NY); MAb Ab-1, clone 9E10 (Oncogene Science), which reacts with human c-Myc at 1:100 dilution; MAb anti-C-erbB-2, clone CB11 (Biogenex) at 1:80 dilution; MAb anti-EGFR, clone E30 (Merck, Darmstadt, Germany) at 1:15 dilution.

Techniques: Over Expression

( a ) Representative immunoblots corresponding to total and phosphorylated protein content measured in the nuclear and cytosolic fractions, before (Pre), immediately (+0 h) and 3 h (+3 h) after the CE and SIE trials. p-p38 MAPK Thr180/Tyr182 : bottom band at ~38 kDa; PHF20: top band at ~105 kDa. No band was detected in the nuclear fractions for p-ACC Ser79 . ( b ) Confirmation of the p53 antibody specificity; samples were run beside an untagged full length p53 recombinant human protein and blotted against both total-p53 (positive control) and p-p53 Ser15 (negative control) antibodies. S: sample; RP: p53 recombinant protein. ( c ) Histone H3 and LDHA were used as indicators of cytosolic and nuclear enrichment, respectively. N: nuclear fractions; C: cytosolic fractions. ( d ) Whole-lane Coomassie blue staining for both nuclear and cytosolic fractions, and ( e ) histone H3 (nuclear) and GAPDH (cytosolic), were used to verify equal loading between lanes. The immunoblot and whole-lane Coomassie images in this figure were cropped to improve the conciseness and clarity of the presentation.

Journal: Scientific Reports

Article Title: Sprint-interval but not continuous exercise increases PGC-1α protein content and p53 phosphorylation in nuclear fractions of human skeletal muscle

doi: 10.1038/srep44227

Figure Lengend Snippet: ( a ) Representative immunoblots corresponding to total and phosphorylated protein content measured in the nuclear and cytosolic fractions, before (Pre), immediately (+0 h) and 3 h (+3 h) after the CE and SIE trials. p-p38 MAPK Thr180/Tyr182 : bottom band at ~38 kDa; PHF20: top band at ~105 kDa. No band was detected in the nuclear fractions for p-ACC Ser79 . ( b ) Confirmation of the p53 antibody specificity; samples were run beside an untagged full length p53 recombinant human protein and blotted against both total-p53 (positive control) and p-p53 Ser15 (negative control) antibodies. S: sample; RP: p53 recombinant protein. ( c ) Histone H3 and LDHA were used as indicators of cytosolic and nuclear enrichment, respectively. N: nuclear fractions; C: cytosolic fractions. ( d ) Whole-lane Coomassie blue staining for both nuclear and cytosolic fractions, and ( e ) histone H3 (nuclear) and GAPDH (cytosolic), were used to verify equal loading between lanes. The immunoblot and whole-lane Coomassie images in this figure were cropped to improve the conciseness and clarity of the presentation.

Article Snippet: The specificity of the p53 antibody was assessed by blotting samples beside a commercially-available, untagged, full-length p53 recombinant human protein (Aviva Systems Biology, AEP00002) ( ).

Techniques: Western Blot, Recombinant, Positive Control, Negative Control, Staining

Protein content of nuclear ( a ) and cytosolic ( b ) p53, of nuclear ( c ) and cytosolic ( d ) PHF20, and of nuclear ( e ) and cytosolic ( f ) p-p53 Ser15 before (Pre), immediately (+0 h) and 3 h (+3 h) after the CE and SIE trials. Open circles (CE) and closed triangles (SIE) represent individual values. Primary effects were analysed using two-way ANOVA with repeated measures for time followed by Tukey’s honestly significant difference post-hoc test for pairwise comparisons. * P < 0.05 vs . Pre; ‡ P < 0.05 vs . CE at the same time point. Individual data points and mean bars are plotted. n = 9 for each type of exercise.

Journal: Scientific Reports

Article Title: Sprint-interval but not continuous exercise increases PGC-1α protein content and p53 phosphorylation in nuclear fractions of human skeletal muscle

doi: 10.1038/srep44227

Figure Lengend Snippet: Protein content of nuclear ( a ) and cytosolic ( b ) p53, of nuclear ( c ) and cytosolic ( d ) PHF20, and of nuclear ( e ) and cytosolic ( f ) p-p53 Ser15 before (Pre), immediately (+0 h) and 3 h (+3 h) after the CE and SIE trials. Open circles (CE) and closed triangles (SIE) represent individual values. Primary effects were analysed using two-way ANOVA with repeated measures for time followed by Tukey’s honestly significant difference post-hoc test for pairwise comparisons. * P < 0.05 vs . Pre; ‡ P < 0.05 vs . CE at the same time point. Individual data points and mean bars are plotted. n = 9 for each type of exercise.

Article Snippet: The specificity of the p53 antibody was assessed by blotting samples beside a commercially-available, untagged, full-length p53 recombinant human protein (Aviva Systems Biology, AEP00002) ( ).

Techniques:

p53 ( a ), and PGC-1α ( b ) mRNA content before (Pre), immediately (+0 h), and 3 h (+3 h) after the CE and SIE trials, expressed relative to control (cyclophilin, glyceraldehyde 3-phosphate dehydrogenase [GAPDH], and beta-2-microglobulin [B2M] housekeeping genes). Open circles (CE) and closed triangles (SIE) represent individual values. Primary effects were analysed using two-way ANOVA with repeated measures for time followed by Tukey’s honestly significant difference post-hoc test for pairwise comparisons. * P < 0.05 vs . Pre. Individual data points and mean bars are plotted. n = 9 for each type of exercise.

Journal: Scientific Reports

Article Title: Sprint-interval but not continuous exercise increases PGC-1α protein content and p53 phosphorylation in nuclear fractions of human skeletal muscle

doi: 10.1038/srep44227

Figure Lengend Snippet: p53 ( a ), and PGC-1α ( b ) mRNA content before (Pre), immediately (+0 h), and 3 h (+3 h) after the CE and SIE trials, expressed relative to control (cyclophilin, glyceraldehyde 3-phosphate dehydrogenase [GAPDH], and beta-2-microglobulin [B2M] housekeeping genes). Open circles (CE) and closed triangles (SIE) represent individual values. Primary effects were analysed using two-way ANOVA with repeated measures for time followed by Tukey’s honestly significant difference post-hoc test for pairwise comparisons. * P < 0.05 vs . Pre. Individual data points and mean bars are plotted. n = 9 for each type of exercise.

Article Snippet: The specificity of the p53 antibody was assessed by blotting samples beside a commercially-available, untagged, full-length p53 recombinant human protein (Aviva Systems Biology, AEP00002) ( ).

Techniques: Control

Primers used for real-time RT-PCR analyses of mRNA expression.

Journal: Scientific Reports

Article Title: Sprint-interval but not continuous exercise increases PGC-1α protein content and p53 phosphorylation in nuclear fractions of human skeletal muscle

doi: 10.1038/srep44227

Figure Lengend Snippet: Primers used for real-time RT-PCR analyses of mRNA expression.

Article Snippet: The specificity of the p53 antibody was assessed by blotting samples beside a commercially-available, untagged, full-length p53 recombinant human protein (Aviva Systems Biology, AEP00002) ( ).

Techniques: Quantitative RT-PCR, Expressing